Gene · 6624
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long noncoding RNA LGALS8-AS1 promotes angiogenesis and brain metastases in non-small cell lung cancer. | Acta Biochim Pol | 2023 | 37716002 | PubTator, text mining | PubMed |
| TurboID-EV: Proteomic Mapping of Recipient Cellular Proteins Proximal to Small Extracellular Vesicles. | Anal Chem | 2023 | 37709279 | PubTator, text mining | PubMed |
| Therapeutic effects of medicinal plants and their constituents on lung cancer, in vitro, in vivo and clinical evidence. | J Cell Mol Med | 2023 | 37697969 | PubTator, text mining | PubMed |
| Can β-catenin, Tenascin and Fascin be potential biomarkers for personalized therapy in Gastric carcinoma? | J Immunoassay Immunochem | 2023 | 37694977 | PubTator, text mining | PubMed |
| Tumor-associated endothelial cell prognostic risk model and tumor immune environment modulation in liver cancer based on single-cell and bulk RNA sequencing: Experimental verification. | Int Immunopharmacol | 2023 | 37690233 | PubTator, text mining | PubMed |
| Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis. | Cancers (Basel) | 2023 | 37686696 | PubTator, text mining | PubMed |
| Patent Foramen Ovale May Decrease the Risk of Left Atrial Thrombosis in Stroke Patients With Atrial Fibrillation. | J Stroke | 2023 | 37667456 | PubTator, text mining | PubMed |
| Editorial: Exploring cancer stem cells signaling pathways. | Front Oncol | 2023 | 37664073 | PubTator, text mining | PubMed |
| Single particle tracking reveals SARS-CoV-2 regulating and utilizing dynamic filopodia for viral invasion. | Sci Bull (Beijing) | 2023 | 37661543 | PubTator, text mining | PubMed |
| Fascin in migration and metastasis of breast cancer cells - A review. | Adv Med Sci | 2023 | 37660543 | PubTator, text mining | PubMed |
| The effect of capacity building evidence-based medicine training on its implementation among healthcare professionals in Southwest Ethiopia: a controlled quasi-experimental outcome evaluation. | BMC Med Inform Decis Mak | 2023 | 37653419 | PubTator, text mining | PubMed |
Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential Therapeutic Targets in Human IDH Mutant High-Grade Gliomas. | J Proteome Res | 2023 | 37651309 | PubTator, text mining | PubMed |
| Whole Blood-Derived circUSP10 Acts as a Diagnostic Biomarker in Patients With Early-Stage Non-Small-Cell Lung Cancer. | Cell Transplant | 2023 | 37632352 | PubTator, text mining | PubMed |
| Drug Discovery and Development of miRNA-Based Nucleotide Drugs for Gastrointestinal Cancer. | Biomedicines | 2023 | 37626731 | PubTator, text mining | PubMed |
| Analysis of Genes Related to Invadopodia Formation and CTTN in Oral Squamous Cell Carcinoma-A Systematic Gene Expression Analysis. | Curr Issues Mol Biol | 2023 | 37623256 | PubTator, text mining | PubMed |
| Identification and validation of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with lung adenocarcinoma. | Sci Rep | 2023 | 37604869 | PubTator, text mining | PubMed |
| Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization. | J Transl Med | 2023 | 37596693 | PubTator, text mining | PubMed |
| ALKBH5 inhibitors as a potential treatment strategy in heart failure-inferences from gene expression profiling. | Front Cardiovasc Med | 2023 | 37583580 | PubTator, text mining | PubMed |
| Identification of LncPVT1 and CircPVT1 as prognostic biomarkers in human colorectal polyps. | Sci Rep | 2023 | 37573419 | PubTator, text mining | PubMed |
| STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway. | Mol Cancer | 2023 | 37573301 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6624/papers?page=13